MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES

被引:14
|
作者
LIUZZI, GM
MASTROIANNI, CM
FANELLI, M
MASSETTI, AP
VULLO, V
DELIA, S
RICCIO, P
机构
[1] UNIV BARI,DEPT BIOCHEM & MOLEC BIOL,I-70126 BARI,ITALY
[2] CNR,CTR STUDY MITOCHONDRIA & ENERGET METAB,I-70126 BARI,ITALY
[3] UNIV BARI,INST HYG,CHAIR MED STAT,BARI,ITALY
[4] UNIV ROMA LA SAPIENZA,DEPT INFECT & TROP DIS,ROME,ITALY
关键词
PROTEASES; MYELIN BASIC PROTEIN; DEMYELINATION; CEREBROSPINAL FLUID; AIDS DEMENTIA COMPLEX; PML; TOXOPLASMOSIS; HIV-1;
D O I
10.1097/00001756-199412300-00040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
DEGRADATION of purified myelin basic protein (MBP) was studied by SDS gel electrophoresis after addition of CSF samples obtained from HIV-1-infected patients. An increase in MBP degradation was detected in patients with neurological complications, such as AIDS dementia complex (ADC) or progressive multifocal leukoencephalopathy (PML), when compared with patients with no neurological symptoms (NA) or with other neurological opportunistic infections (OI). In the ADC and PML patients, in addition to CSF proteolytic activity, an increase in CSF-MBP levels and presence of white matter lesions were also observed by neuroimaging (MRI). In other opportunistic infections of the brain, MBP levels but not anti-MBP proteolytic activity increased. Results suggest the involvement of proteases in the virus-induced demyelination.
引用
收藏
页码:157 / 160
页数:4
相关论文
共 50 条
  • [1] Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients
    Vignoli, M
    Stecca, B
    Furlini, G
    Re, MC
    Mantovani, V
    Zauli, G
    Visani, G
    Colangeli, V
    La Placa, M
    AIDS, 1998, 12 (09) : 999 - 1005
  • [2] Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review
    Gianotti, Nicola
    Soria, Alessandro
    Lazzarin, Adriano
    NEW MICROBIOLOGICA, 2007, 30 (02): : 79 - 88
  • [3] HIV-2-INFECTED PATIENTS SURVIVE LONGER THAN HIV-1-INFECTED PATIENTS
    WHITTLE, H
    MORRIS, J
    TODD, J
    CORRAH, T
    SABALLY, S
    BANGALI, J
    NGOM, PT
    ROLFE, M
    WILKINS, A
    AIDS, 1994, 8 (11) : 1617 - 1620
  • [4] Association of osteonecrosis and osteoporosis in HIV-1-infected patients
    Fessel, W. Jeffrey
    Chau, Quyen
    Leong, Davis
    AIDS, 2011, 25 (15) : 1877 - 1880
  • [5] Oral diseases, mycology and periodontal microbiology of HIV-1-infected women
    Brady, LJ
    Walker, C
    Oxford, GE
    Stewart, C
    Magnusson, I
    McArthur, W
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 1996, 11 (06): : 371 - 380
  • [6] Activity of Cellular Thymidine Kinase 1 in PBMC of HIV-1-Infected Patients: Novel Therapy Marker
    B. Gröschel
    V. Miller
    H. W. Doerr
    J. Cinatl Jr.
    Infection, 2000, 28 : 209 - 213
  • [7] Activity of cellular thymidine kinase 1 in PBMC of HIV-1-infected patients:: Novel therapy marker
    Gröschel, B
    Miller, V
    Doerr, HW
    Cinatl, J
    INFECTION, 2000, 28 (04) : 209 - 213
  • [8] Disorders of Body Fat Distribution in HIV-1-Infected Patients
    Moreno, Santiago
    Miralles, Celia
    Negredo, Eugenia
    Domingo, Pere
    Estrada, Vicente
    Gutierrez, Felix
    Lozano, Fernando
    Martinez, Esteban
    AIDS REVIEWS, 2009, 11 (03) : 126 - 134
  • [9] Uncovering HIV-1-infected cells
    Veillette, Maxime
    Richard, Jonathan
    Finzi, Andres
    ONCOTARGET, 2015, 6 (26) : 21791 - 21792
  • [10] ANTI-HIV ACTIVITY OF THE COMBINATION OF DIDANOSINE AND HYDROXYUREA IN HIV-1-INFECTED INDIVIDUALS
    BIRON, F
    LUCHT, F
    PEYRAMOND, D
    FRESARD, A
    VALLET, T
    NUGIER, F
    GRANGE, J
    MALLEY, S
    HAMEDISANGSARI, F
    VILA, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 (01) : 36 - 40